Novartis AG

NOVN

Company Profile

  • Business description

    Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

  • Contact

    Lichtstrasse 35
    Basel4056
    CHE

    T: +41 613241111

    E: [email protected]

    https://www.novartis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    75,883

Stocks News & Analysis

stocks

Another incredible quarter from Microsoft

We were wrong when we thought last quarter would be hard to top.
stocks

10 best US dividend aristocrats to buy now—including a surprise outperformer

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks

Leading ASX players in this field look materially overvalued

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,999.0016.40-0.18%
CAC 407,837.7824.18-0.31%
DAX 4024,240.5721.65-0.09%
Dow JONES (US)44,461.28171.71-0.38%
FTSE 1009,172.8235.880.39%
HKSE24,773.33403.60-1.60%
NASDAQ21,129.6731.380.15%
Nikkei 22541,069.82415.121.02%
NZX 50 Index12,823.7432.23-0.25%
S&P 5006,362.907.96-0.12%
S&P/ASX 2008,742.8013.60-0.16%
SSE Composite Index3,573.2142.51-1.18%

Market Movers